Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-18

Clinical Trial Update: Zinc and Selenium Bioactivity [NA]

View source ↗

Summary

A completed clinical trial from the University of Lahore evaluated zinc and selenium bioactivity in the context of immunomodulatory drugs and tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selenium (selenium)
  • ZINC (Zinc chloride)

Snippet

Sponsor: University of Lahore | Conditions: Immunomodulatory Drugs, Tuberculosis | NA | Status: COMPLETED